drugset / Trial / NCT00000226

Alternate-Day Buprenorphine Administration. Phase VII - 8

NCT00000226

Treatment

Summary

The purpose of this study is to determine if four times a subjects daily maintenance dose will hold for 96 hours without changes in agonist and antagonist effects under open dosing conditions.

Timeline

Start
1994-11
Primary completion
Completion

Publications

  • Background Patry, Bicket, Tzanis, Badger (in preparation). Every fourth day dosing with buprenorphine (2) A comparison of four different dosing schedules under open and choice procedures.. Patry, Bickel, Tzanis, Badger (in preparation). Every fourth day dosing with buprenorphine (2) A comparison of four different dosing schedules under open and choice procedures.

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified